HindustanTimes Mon,22 Sep 2014

Ranbaxy slumps, Sun Pharma surges on $3.2-billion acquisition

Reuters  Mumbai, April 07, 2014
First Published: 09:36 IST(7/4/2014) | Last Updated: 10:20 IST(7/4/2014)

Shares in India's Ranbaxy Laboratories Ltd fell as much as 3.2% on profit-taking after Sun Pharmaceutical Industries Ltd said it will buy the company in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker.

Ranbaxy shares had surged 32.6 % in six consecutive sessions of gains till Friday's close.

Sun Pharmaceutical shares rose as much as 4 %.

Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own. Daiichi Sankyo said in a statement that it will hold a stake of about 9 % in Sun Pharmaceutical after the deal.

more from Business

Airlines oppose govt policy on connectivity to remote areas

Airlines and private charter operators have opposed the government's draft policy on air connectivity to regional and remote areas, saying it will have severe impact on their financial strength.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved